The award recognizes outstanding basic science research. Leading achievements in clinical and/or translational research can also qualify. Nominations are due by 5 p.m. on Nov. 8
Nominations for the 2022-2023 Hyman L. Battle Distinguished Cancer Research Award are now being accepted.
The award recognizes outstanding basic science research. Leading achievements in clinical and/or translational research can also qualify.
Nominations are due by 5 p.m. on Nov. 8.
More information can be found in the memo from Blossom Damania and Shelley Earp linked here.